Endoskopie einmal ganz anders - 500 Beiträge pro Seite
eröffnet am 28.09.09 21:51:00 von
neuester Beitrag 02.04.10 17:01:44 von
neuester Beitrag 02.04.10 17:01:44 von
Beiträge: 16
ID: 1.153.351
ID: 1.153.351
Aufrufe heute: 0
Gesamt: 1.139
Gesamt: 1.139
Aktive User: 0
ISIN: IL0010865371 · WKN: 806006
Feedback
Schaut Euch einfach mal diese Aktie, besser gesagt dieses Unternehmen an und urteilt selbst!!!!!
Jeder der schon einmal eine Endoskopie hat über sich ergehen lassen müssen, sollte sich mal schlau machen.
Da sollte man vielleicht mal dabei sein.
Ist aber nur meine Meinung.
Wenn das keine Zukunft hat sollten wir vielleicht wieder auf Blechkeidung umsteigen.
givenimaging.com
Trotz allem wünsche ich allen gute Trades
didi58
Jeder der schon einmal eine Endoskopie hat über sich ergehen lassen müssen, sollte sich mal schlau machen.
Da sollte man vielleicht mal dabei sein.
Ist aber nur meine Meinung.
Wenn das keine Zukunft hat sollten wir vielleicht wieder auf Blechkeidung umsteigen.
givenimaging.com
Trotz allem wünsche ich allen gute Trades
didi58
Antwort auf Beitrag Nr.: 38.072.793 von didi58 am 28.09.09 21:51:00Über 400 Leser und kein Kommentar.
Auch sehr selten.
didi58
Auch sehr selten.
didi58
-naja - 10 euro - das ist nicht viel - was soll man dazu sagen...
Hey Kurumba
auch noch dabei oder schon wieder,
ist auf jeden Fall immer noch sehr zukunftsträchtig und wieder auf dem Weg nach oben.
Die haben immer noch lange nicht ihr Potenzial ausgeschöpft und das GUTE ist, unbekannt, steigt langsam aber stetig, fällt allerdings auch sehr stark mit dem Markt, aber da muss man durch
didi58
auch noch dabei oder schon wieder,
ist auf jeden Fall immer noch sehr zukunftsträchtig und wieder auf dem Weg nach oben.
Die haben immer noch lange nicht ihr Potenzial ausgeschöpft und das GUTE ist, unbekannt, steigt langsam aber stetig, fällt allerdings auch sehr stark mit dem Markt, aber da muss man durch
didi58
ich bin einfach dabei geblieben - lachen musste ich, als hier ein panikheini die für 2,50 verkauft hat
Trading Spotlight
AUA
ab heute geht es wieder up
nö, doch nicht - dann eben ein andermal- war von Zacks rank 1, aber...
mm- heute 12 euronen - im februar gibtes divi
Dividende?
Quelle?
Ich dachte das wäre letztes Jahr einmalig gewesen?
LG
didi58
Quelle?
Ich dachte das wäre letztes Jahr einmalig gewesen?
LG
didi58
Ja, jetzt ist Bewegung angesagt
Antwort auf Beitrag Nr.: 39.043.630 von didi58 am 02.03.10 18:10:36Es hat halt schon was, unbekannt, steigt laaaangsaaam und in ein paar Jahren dürfen sie auch mal bekannt werden und weiter steigen
Antwort auf Beitrag Nr.: 39.188.675 von didi58 am 22.03.10 11:33:56Und im Schnitt 20% Wachstum pro Jahr. JEDES JAHR!!!!
Antwort auf Beitrag Nr.: 39.188.686 von didi58 am 22.03.10 11:36:51Schon gehts weiter:
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Deal Expands GI Diagnostics Portfolio and Strengthens Leadership Position; Acquisition Will Contribute More Than $20 Million to Revenues During Next 12 Months; Sierra Scientific Will Contribute to Bottom Line, Net of Transaction Expenses
YOQNEAM, ISRAEL -- (Marketwire) -- 03/22/10 -- Given Imaging Ltd (NASDAQ: GIVN) today announced that it has signed a definitive agreement to acquire privately-held Sierra Scientific Instruments (Sierra Scientific) for $35 million in cash. Sierra Scientific is the leading provider of specialty diagnostic devices for the gastrointestinal (GI) tract and will become a wholly-owned subsidiary of the Company. Given Imaging is acquiring Sierra Scientific from Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care.
The Company expects that the deal will close and become effective on or about April 1, 2010. Sierra Scientific is profitable, has a debt-free balance sheet and recorded unaudited revenues of approximately $18 million in 2009. The Company expects that the acquisition, net of transaction expenses, will be accretive within a short period. Coupled with Given Imaging's existing Bravo® pH Monitoring System, the acquisition positions Given Imaging as the leader in the market for esophageal diagnostics, including manometry as well as pH and impedance monitoring, for which the 2009 served market was estimated at $60 million. The Company intends to expand this market by building on this leadership position.
"Sierra Scientific is a strong, well managed company respected by the GI community for its cutting-edge products which deliver reliable performance. This acquisition strengthens Given Imaging's position as the global leader in the gastroesophageal diagnostic market. With manometry, impedance, catheter pH and Bravo wireless pH products, we advance our vision of providing total world-class solutions to our GI customers' evolving product needs," said Homi Shamir, president and chief executive officer, Given Imaging. "From a financial standpoint, acquiring Sierra will increase our revenue base, and ultimately profitability. It enables us to diversify our product and geographic revenues through access to additional best-in-class products, people, and manufacturing assets. We plan to offer our full product portfolio to our expanded customer base to drive broader use of all of our products."
2010 Guidance
Given Imaging will revise its 2010 revenue and EPS guidance, which it plans to disclose in its first quarter 2010 financial results press release scheduled for May 11, 2010.
About Sierra Scientific Instruments
Sierra Scientific is recognized as the worldwide leader in high-resolution manometry through its ManoScan™ family of products. Additionally, Sierra Scientific offers a line of reflux monitoring solutions (AccuTrac™ and Digitrapper™), as well as its Polygraf ID® stationary gastrointestinal function testing platform. Sierra Scientifics' 175 employees are located in two main facilities, with more than 70 in its Los Angeles headquarters and approximately 100 in an efficient, state-of-the-art manufacturing facility in Vietnam. In 2009, approximately 60% of revenues came from US sales and 40% from the rest of the world, principally Europe.
Sierra Scientific merged with a division of Alpine Biomed Corporation, a leading specialty diagnostic device company owned by Water Street, in September, 2009.
"Given Imaging's agreement to purchase Sierra Scientific affirms the successful execution of our strategy to build the market leader in gastrodiagnostic devices. All of our key stakeholders -- customers, employees and investors -- will benefit from Given Imaging's global network of resources and broad portfolio of solutions," said Ned Villers, a partner with Water Street.
"Having recently expanded our manufacturing capabilities and customer base through our merger with Alpine Biomed's gastroenterology division, we look to this acquisition by Given Imaging to further amplify our strengths in delivering best-in-class specialty GI diagnostic tools. This has been our goal since we founded Sierra," said Tom Parks, president and chief executive officer, Sierra Scientific Instruments. "We have always respected Given Imaging's emphasis on continuous innovation and customer service and are pleased to become part of their company. We believe that our product lines, business philosophy, and customer profile complement each other nicely."
Sierra Scientifics' business breaks down into two areas:
1. Manometry/Motility testing (ManoScan™, PolyGraf ID): Esophageal
manometry is a test to measure the pressure inside the esophagus. During
this procedure, a thin, pressure-sensitive tube, or "catheter," is
passed through the patient's mouth or nose into the stomach. The test
measures the pressure of the muscle contractions along several sections
of the tube. Esophageal manometry may be combined with impedance
monitoring and is often referred to as upper GI motility testing.
Physicians use motility testing in patients with GERD, swallowing
disorders, chronic constipation, chronic abdominal pain, intestinal
pseudo-obstruction, and unexplained nausea and vomiting.(1) The test
evaluates how well a patient's digestive tract muscles are functioning.
Sierra Scientific pioneered the development of high-resolution solid
state manometry in which motility physiology is clearly visualized
through the length of the esophagus. This technology, embodied in Sierra
Scientifics' industry-leading ManoScan family of equipment, greatly
simplifies these clinical procedures and provides greater diagnostic
accuracy than the conventional low resolution technology it replaces.
2. Reflux monitoring (AccuTrac and Digitrapper): Reflux monitoring involves
measurement of pH or a combination of pH and impedance in the esophagus.
pH monitoring measures acid reflux from the stomach into the esophagus
for patients thought to have gastroesophageal reflux disease, or GERD.
When using these products esophageal pH monitoring is performed by
passing a thin plastic catheter through one nostril and placing it in
the esophagus. The catheter is then attached to a recorder that the
patient wears on a shoulder strap or around their waist to capture the
pH measurements of the esophagus. The patient is sent home with the
catheter and recorder and returns the next day to have the catheter
removed. The data from the recorder is downloaded into a computer for
analysis.(2)
Impedance monitoring detects reflux events independent of the pH
allowing for identification of acid and non-acid reflux episodes as well
as providing esophageal transit data. Impedance monitoring is often
combined with pH monitoring and used in GERD patients whose symptoms are
not resolved with proton pump inhibitor (PPI) therapy. It can also be
combined with manometry to provide a more complete picture of esophageal
motility.
(1) http://www.mountsinai.org/Education/School%20of%20Medicine/F…
(2) http://www.medicinenet.com/esophageal_ph_monitoring/article.…
About GERD
Datamonitor estimates that around 147 million people in the US, Japan, France, Germany, Italy, Spain and the UK (around 20% of the population) suffer from GERD. Gastroesophageal reflux (also known as heartburn) occurs when contents from the stomach flow back up into the esophagus. Occasional heartburn is normal, but chronic heartburn caused by GERD can affect daily activities and damage the esophagus. Left untreated, GERD may also lead to more serious medical problems:
-- Difficulty swallowing (dysphagia)
-- Painful swallowing (odynophagia)
-- Narrowing of the esophagus (strictures)
-- Barrett's esophagus (pre-cancerous lesions)
-- Chronic hoarseness or laryngitis
-- Respiratory problems (coughing, asthma)
About Given Imaging Ltd.
Since 2001, Given Imaging has advanced gastrointestinal visualization by developing innovative, patient-friendly tools based on its PillCam® Platform. PillCam® capsule endoscopy provides physicians with natural images of the small intestine via PillCam® SB, the esophagus through PillCam® ESO and the colon with PillCam® COLON [PillCam COLON is not cleared for use in the USA]. The PillCam® capsules are miniature video cameras that patients ingest. Given Imaging's other capsule products include Agile™ patency capsule, to verify intestinal patency, and Bravo®, the only wireless, catheter-free, 48-hour pH test commercially available for pH testing to assess gastroesophageal reflux disease (GERD). Given Imaging's products use cutting-edge, wireless technology and advanced software to enable gastroenterologists to visualize diseases of the esophagus, small bowel and colon. All Given Imaging products allow patients to maintain normal activities. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel, with operating subsidiaries in the United States, Germany, France, Japan, Australia and Singapore. For more information, please visit www.givenimaging.com.
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Deal Expands GI Diagnostics Portfolio and Strengthens Leadership Position; Acquisition Will Contribute More Than $20 Million to Revenues During Next 12 Months; Sierra Scientific Will Contribute to Bottom Line, Net of Transaction Expenses
YOQNEAM, ISRAEL -- (Marketwire) -- 03/22/10 -- Given Imaging Ltd (NASDAQ: GIVN) today announced that it has signed a definitive agreement to acquire privately-held Sierra Scientific Instruments (Sierra Scientific) for $35 million in cash. Sierra Scientific is the leading provider of specialty diagnostic devices for the gastrointestinal (GI) tract and will become a wholly-owned subsidiary of the Company. Given Imaging is acquiring Sierra Scientific from Water Street Healthcare Partners, a leading private equity firm focused exclusively on health care.
The Company expects that the deal will close and become effective on or about April 1, 2010. Sierra Scientific is profitable, has a debt-free balance sheet and recorded unaudited revenues of approximately $18 million in 2009. The Company expects that the acquisition, net of transaction expenses, will be accretive within a short period. Coupled with Given Imaging's existing Bravo® pH Monitoring System, the acquisition positions Given Imaging as the leader in the market for esophageal diagnostics, including manometry as well as pH and impedance monitoring, for which the 2009 served market was estimated at $60 million. The Company intends to expand this market by building on this leadership position.
"Sierra Scientific is a strong, well managed company respected by the GI community for its cutting-edge products which deliver reliable performance. This acquisition strengthens Given Imaging's position as the global leader in the gastroesophageal diagnostic market. With manometry, impedance, catheter pH and Bravo wireless pH products, we advance our vision of providing total world-class solutions to our GI customers' evolving product needs," said Homi Shamir, president and chief executive officer, Given Imaging. "From a financial standpoint, acquiring Sierra will increase our revenue base, and ultimately profitability. It enables us to diversify our product and geographic revenues through access to additional best-in-class products, people, and manufacturing assets. We plan to offer our full product portfolio to our expanded customer base to drive broader use of all of our products."
2010 Guidance
Given Imaging will revise its 2010 revenue and EPS guidance, which it plans to disclose in its first quarter 2010 financial results press release scheduled for May 11, 2010.
About Sierra Scientific Instruments
Sierra Scientific is recognized as the worldwide leader in high-resolution manometry through its ManoScan™ family of products. Additionally, Sierra Scientific offers a line of reflux monitoring solutions (AccuTrac™ and Digitrapper™), as well as its Polygraf ID® stationary gastrointestinal function testing platform. Sierra Scientifics' 175 employees are located in two main facilities, with more than 70 in its Los Angeles headquarters and approximately 100 in an efficient, state-of-the-art manufacturing facility in Vietnam. In 2009, approximately 60% of revenues came from US sales and 40% from the rest of the world, principally Europe.
Sierra Scientific merged with a division of Alpine Biomed Corporation, a leading specialty diagnostic device company owned by Water Street, in September, 2009.
"Given Imaging's agreement to purchase Sierra Scientific affirms the successful execution of our strategy to build the market leader in gastrodiagnostic devices. All of our key stakeholders -- customers, employees and investors -- will benefit from Given Imaging's global network of resources and broad portfolio of solutions," said Ned Villers, a partner with Water Street.
"Having recently expanded our manufacturing capabilities and customer base through our merger with Alpine Biomed's gastroenterology division, we look to this acquisition by Given Imaging to further amplify our strengths in delivering best-in-class specialty GI diagnostic tools. This has been our goal since we founded Sierra," said Tom Parks, president and chief executive officer, Sierra Scientific Instruments. "We have always respected Given Imaging's emphasis on continuous innovation and customer service and are pleased to become part of their company. We believe that our product lines, business philosophy, and customer profile complement each other nicely."
Sierra Scientifics' business breaks down into two areas:
1. Manometry/Motility testing (ManoScan™, PolyGraf ID): Esophageal
manometry is a test to measure the pressure inside the esophagus. During
this procedure, a thin, pressure-sensitive tube, or "catheter," is
passed through the patient's mouth or nose into the stomach. The test
measures the pressure of the muscle contractions along several sections
of the tube. Esophageal manometry may be combined with impedance
monitoring and is often referred to as upper GI motility testing.
Physicians use motility testing in patients with GERD, swallowing
disorders, chronic constipation, chronic abdominal pain, intestinal
pseudo-obstruction, and unexplained nausea and vomiting.(1) The test
evaluates how well a patient's digestive tract muscles are functioning.
Sierra Scientific pioneered the development of high-resolution solid
state manometry in which motility physiology is clearly visualized
through the length of the esophagus. This technology, embodied in Sierra
Scientifics' industry-leading ManoScan family of equipment, greatly
simplifies these clinical procedures and provides greater diagnostic
accuracy than the conventional low resolution technology it replaces.
2. Reflux monitoring (AccuTrac and Digitrapper): Reflux monitoring involves
measurement of pH or a combination of pH and impedance in the esophagus.
pH monitoring measures acid reflux from the stomach into the esophagus
for patients thought to have gastroesophageal reflux disease, or GERD.
When using these products esophageal pH monitoring is performed by
passing a thin plastic catheter through one nostril and placing it in
the esophagus. The catheter is then attached to a recorder that the
patient wears on a shoulder strap or around their waist to capture the
pH measurements of the esophagus. The patient is sent home with the
catheter and recorder and returns the next day to have the catheter
removed. The data from the recorder is downloaded into a computer for
analysis.(2)
Impedance monitoring detects reflux events independent of the pH
allowing for identification of acid and non-acid reflux episodes as well
as providing esophageal transit data. Impedance monitoring is often
combined with pH monitoring and used in GERD patients whose symptoms are
not resolved with proton pump inhibitor (PPI) therapy. It can also be
combined with manometry to provide a more complete picture of esophageal
motility.
(1) http://www.mountsinai.org/Education/School%20of%20Medicine/F…
(2) http://www.medicinenet.com/esophageal_ph_monitoring/article.…
About GERD
Datamonitor estimates that around 147 million people in the US, Japan, France, Germany, Italy, Spain and the UK (around 20% of the population) suffer from GERD. Gastroesophageal reflux (also known as heartburn) occurs when contents from the stomach flow back up into the esophagus. Occasional heartburn is normal, but chronic heartburn caused by GERD can affect daily activities and damage the esophagus. Left untreated, GERD may also lead to more serious medical problems:
-- Difficulty swallowing (dysphagia)
-- Painful swallowing (odynophagia)
-- Narrowing of the esophagus (strictures)
-- Barrett's esophagus (pre-cancerous lesions)
-- Chronic hoarseness or laryngitis
-- Respiratory problems (coughing, asthma)
About Given Imaging Ltd.
Since 2001, Given Imaging has advanced gastrointestinal visualization by developing innovative, patient-friendly tools based on its PillCam® Platform. PillCam® capsule endoscopy provides physicians with natural images of the small intestine via PillCam® SB, the esophagus through PillCam® ESO and the colon with PillCam® COLON [PillCam COLON is not cleared for use in the USA]. The PillCam® capsules are miniature video cameras that patients ingest. Given Imaging's other capsule products include Agile™ patency capsule, to verify intestinal patency, and Bravo®, the only wireless, catheter-free, 48-hour pH test commercially available for pH testing to assess gastroesophageal reflux disease (GERD). Given Imaging's products use cutting-edge, wireless technology and advanced software to enable gastroenterologists to visualize diseases of the esophagus, small bowel and colon. All Given Imaging products allow patients to maintain normal activities. Given Imaging's headquarters, manufacturing and R&D facilities are located in Yoqneam, Israel, with operating subsidiaries in the United States, Germany, France, Japan, Australia and Singapore. For more information, please visit www.givenimaging.com.
jaja - dein wort in gottes ohr
downgrade - schade
DurchsuchenBeitrag zu dieser Diskussion schreiben
Zu dieser Diskussion können keine Beiträge mehr verfasst werden, da der letzte Beitrag vor mehr als zwei Jahren verfasst wurde und die Diskussion daraufhin archiviert wurde.
Bitte wenden Sie sich an feedback@wallstreet-online.de und erfragen Sie die Reaktivierung der Diskussion oder starten Sie eine neue Diskussion.
Investoren beobachten auch:
| Wertpapier | Perf. % |
|---|---|
| -0,73 | |
| +0,23 | |
| +0,94 | |
| +8,87 | |
| -0,34 | |
| +0,23 | |
| -1,16 | |
| -0,49 | |
| -1,50 | |
| -3,03 |
Meistdiskutiert
| Wertpapier | Beiträge | |
|---|---|---|
| 241 | ||
| 102 | ||
| 81 | ||
| 79 | ||
| 75 | ||
| 53 | ||
| 41 | ||
| 38 | ||
| 36 | ||
| 33 |
